Members Area Login

Go to the login page

Want to be a Member?

Click here
Contact us
FAQ

Meet the Board

Your opportunity to meet each member of the board

Meet the Board

Frank Milek

IPEC Europe Chair

Dr. Frank Milek is an industrial pharmacist and has been working in pharmaceutical excipients industry for more than 15 years, specialised in the field of supply chain and distribution. He is registered QP according to EU regulation and responsible at Aug. Hedinger GmbH & Co. KG for Quality, Regulatory Affairs and GMP.

 

Frank is currently the Chair of the GTDP Committee in FECC (European Association of Chemical Distributors) and an active member of the EXCiPACT project.

 

 

 

Frithjof Holtz

IPEC Europe Vice-Chair

Mr. Frithjof Holtz is a biologist and has been working for more than 20 years with Merck, having a long year experience in quality assurance and regulatory affairs.

 

As Director Advocacy he is responsible for the advocacy activities of the pharmaceutical raw materials business of the Merck KGaA Division, Merck Millipore.

 

 

 

Sergio Neves

IPEC Europe Treasurer

Sergio Neves is a Pharmacy graduate of Coimbra University in Portugal and a PhD in Organic Chemistry from Warwick University in the UK.

 

Sergio joined Roquette Freres in 1998 where he currently holds the position of Business Unit Director of the Pharmaceutical and Cosmetics Business Unit.

 

 

 

Hubertus Folttmann

IPEC Europe Secretary

                                                                   

Hubertus Folttmann is currently Head of Association Activities - Pharma Ingredients & Services at BASF SE.

 

Hubertus studied at the College of Pharmacy, Freie Universität Berlin and obtained a PhD in pharmaceutical chemistry from Heinrich Heine Universität Düsseldorf. After 12 years of experience in different functions at the Knoll Group (2001 acquired by Abbott), he joined BASF in 1998.

 

 

 

Christophe Guéchot

 
 

Since 2008, Christophe Guéchot is Regulatory Affairs and Risk Manager for Solvay's products placed on the market in HealthCare, Food & Feed applications.

Pharmacist graduate of the School of Pharmacy, University of Paris, Christophe occupied various functions along the Medicinal drug products life-cycle in different Pharmaceutical groups. He joinded Solvay in 1997 and took the current global position in 2008.

 

 

 

 Karine Roth

 

Karine Roth is a Pharmacist and has more than16 years of experience within Pharmaceutical. She is currently working with Novartis as Global Sourcing QA Lead; her role includes the definition of quality standard for suppliers management (Audit, Quality Agreement, Risk Assessment, complaints, Change management...) and support to Novartis sites for Quality management of global suppliers. Previously, she has worked for Eli Lilly in several management position in Regulatory, Supplier Quality Assurance and Lean Six Sigma.

 

 

 

Amina Faham

 

 

Amina is a Biochemist and earned a Ph.D. degree in Pharmaceutical sciences from school of pharmacy, La Timone France. Amina has over 10 years of pharma industry experience in oral solid dosage forms with emphasis on modified drug release technologies, process development and optimization, production trouble shooting, and project management with companies including Wyeth/Pfizer Pharmaceuticals and Colorcon. Amina has a strong background and experience of drug product development, CGMPs and the concepts of the modern quality systems. She is also Knowledgeable about operating discipline management systems. She joined DOW in Horgen Switzerland in 2011, as a senior pharmaceutical development application manager supporting the business in EMEA region.


 

 

Liz Meehan

 

Liz Meehan is a material scientist with a PhD from City University, London and more than 30 years experience in material characterisation.

She has worked in the pharmaceutical industry for 10 years, in the Pharmaceutical Development department of AstraZeneca, specialising in the field of excipient characterisation, relating excipient properties to functionality in dosage form design. More generally her activities include excipient risk assessment/mitigation for the development of robust pharmaceutical formulations.

   

Newsletter Subscription

Sign up for our subscriber newsletter!